Buhlmann
Buhlmann
BÜHLMANN Laboratories AG is a Swiss-based company with over 45 years of expertise in specialized in vitro diagnostics (IVD). Renowned for its commitment to quality, innovation, and clinical relevance, BÜHLMANN focuses on diagnostic solutions in the fields of gastroenterology, neuroimmunology, allergy, and therapeutic drug monitoring. With CE-IVDR and FDA-cleared assays, and a presence in over 60 countries, BÜHLMANN products are trusted by laboratories, hospitals, and clinicians worldwide for their accuracy, speed, and ease of use.
- fCAL® turbo
A high-throughput, fully automated fecal calprotectin assay for clinical chemistry analyzers. It provides rapid and reliable results for monitoring intestinal inflammation in patients with IBD.
- IBDoc®
The world’s first home-based calprotectin test, allowing IBD patients to monitor their disease activity using a smartphone app, with direct data transfer to their healthcare provider.
- Quantum Blue®
A rapid, quantitative point-of-care test for calprotectin, offering fast results in outpatient settings or smaller labs with limited infrastructure.
- fPELA® turbo
An automated assay for fecal pancreatic elastase, used in the diagnosis of exocrine pancreatic insufficiency. Compatible with a range of clinical chemistry analyzers.
- Therapeutic Drug Monitoring (TDM)
Assays for measuring levels of biologic drugs (e.g. infliximab, adalimumab) and their anti-drug antibodies, aiding in treatment optimization for IBD and autoimmune patients.
